Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Amgen Net Profit Margin 2011-2025 | AMGN

Current and historical net profit margin for Amgen (AMGN) from 2011 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue. Amgen net profit margin for the three months ending June 30, 2025 was .
Amgen Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2025-06-30 $34.92B $6.62B 18.96%
2025-03-31 $34.13B $5.93B 17.39%
2024-12-31 $33.42B $4.09B 12.24%
2024-09-30 $32.53B $4.23B 13.00%
2024-06-30 $30.93B $3.13B 10.12%
2024-03-31 $29.53B $3.76B 12.74%
2023-12-31 $28.19B $6.72B 23.83%
2023-09-30 $26.83B $7.57B 28.20%
2023-06-30 $26.58B $7.98B 30.02%
2023-03-31 $26.19B $7.92B 30.23%
2022-12-31 $26.32B $6.55B 24.89%
2022-09-30 $26.33B $6.84B 25.96%
2022-06-30 $26.38B $6.58B 24.92%
2022-03-31 $26.32B $5.72B 21.75%
2021-12-31 $25.98B $5.89B 22.68%
2021-09-30 $25.77B $5.61B 21.77%
2021-06-30 $25.48B $5.75B 22.55%
2021-03-31 $25.16B $7.09B 28.16%
2020-12-31 $25.42B $7.26B 28.57%
2020-09-30 $24.99B $7.35B 29.42%
2020-06-30 $24.30B $7.30B 30.04%
2020-03-31 $23.97B $7.68B 32.02%
2019-12-31 $23.36B $7.84B 33.57%
2019-09-30 $23.40B $8.07B 34.48%
2019-06-30 $23.56B $7.96B 33.77%
2019-03-31 $23.75B $8.08B 34.00%
2018-12-31 $23.75B $8.39B 35.35%
2018-09-30 $23.32B $2.20B 9.44%
2018-06-30 $23.19B $2.36B 10.19%
2018-03-31 $22.94B $2.22B 9.67%
2017-12-31 $22.85B $1.98B 8.66%
2017-09-30 $23.01B $8.18B 35.54%
2017-06-30 $23.05B $8.17B 35.46%
2017-03-31 $22.93B $7.89B 34.43%
2016-12-31 $22.99B $7.72B 33.59%
2016-09-30 $22.56B $7.59B 33.63%
2016-06-30 $22.47B $7.43B 33.07%
2016-03-31 $22.16B $7.22B 32.57%
2015-12-31 $21.66B $6.94B 32.03%
2015-09-30 $21.46B $6.43B 29.98%
2015-06-30 $20.77B $5.81B 28.00%
2015-03-31 $20.58B $5.71B 27.74%
2014-12-31 $20.06B $5.16B 25.71%
2014-09-30 $19.74B $4.89B 24.74%
2014-06-30 $19.46B $5.01B 25.74%
2014-03-31 $18.96B $4.72B 24.90%
2013-12-31 $18.68B $5.08B 27.21%
2013-09-30 $18.09B $4.85B 26.81%
2013-06-30 $17.66B $4.59B 25.98%
2013-03-31 $17.46B $4.60B 26.32%
2012-12-31 $17.27B $4.35B 25.17%
2012-09-30 $16.82B $4.49B 26.71%
2012-06-30 $16.44B $3.84B 23.34%
2012-03-31 $15.92B $3.74B 23.50%
2011-12-31 $15.58B $3.68B 23.64%
2011-09-30 $15.45B $3.77B 24.41%
2011-06-30 $15.32B $4.55B 29.72%
2011-03-31 $15.17B $4.59B 30.23%
2010-12-31 $15.05B $4.63B 30.74%
2010-09-30 $15.02B $4.54B 30.20%
2010-06-30 $15.02B $4.69B 31.20%
2010-03-31 $14.93B $4.75B 31.84%
2009-12-31 $14.64B $4.61B 31.45%
2009-09-30 $14.58B $4.60B 31.53%
2009-06-30 $14.65B $4.33B 29.59%
2009-03-31 $14.70B $3.97B 27.02%
2008-12-31 $15.00B $4.05B 27.01%
2008-09-30 $15.00B $3.87B 25.83%
2008-06-30 $14.73B $2.95B 20.05%
2008-03-31 $14.70B $3.07B 20.87%
2007-12-31 $14.77B $3.08B 20.84%
2007-09-30 $14.86B $3.16B 21.29%
2007-06-30 $14.86B $4.07B 27.35%
2007-03-31 $14.74B $3.06B 20.76%
2006-12-31 $14.27B $2.95B 20.68%
2006-09-30 $13.70B $2.94B 21.46%
2006-06-30 $13.25B $2.81B 21.18%
2006-03-31 $12.81B $3.82B 29.82%
2005-12-31 $12.43B $3.67B 29.56%
2005-09-30 $12.07B $3.54B 29.33%
2005-06-30 $11.63B $2.81B 24.15%
2005-03-31 $11.04B $2.53B 22.89%
2004-12-31 $10.55B $2.36B 22.40%
2004-09-30 $9.99B $2.22B 22.24%
2004-06-30 $9.48B $2.60B 27.39%
2004-03-31 $8.94B $2.46B 27.48%
2003-12-31 $8.36B $2.26B 27.03%
2003-09-30 $7.78B $2.17B 27.88%
2003-06-30 $7.07B $-1.05B -14.80%
2003-03-31 $6.28B $-1.24B -19.78%
2002-12-31 $5.52B $-1.39B -25.22%
2002-09-30 $4.88B $-1.69B -34.54%
2002-06-30 $4.39B $1.25B 28.42%
2002-03-31 $4.12B $1.16B 28.04%
2001-12-31 $4.02B $1.12B 27.89%
2001-09-30 $3.84B $1.17B 30.39%
2001-06-30 $3.79B $1.20B 31.58%
2001-03-31 $3.72B $1.18B 31.69%
2000-12-31 $3.63B $1.14B 31.39%
2000-09-30 $3.61B $1.21B 33.56%
2000-06-30 $3.50B $1.15B 32.87%
2000-03-31 $3.41B $1.12B 32.74%
1999-12-31 $3.34B $1.10B 32.83%
1999-09-30 $3.17B $1.05B 33.26%
1999-06-30 $3.02B $0.98B 32.25%
1999-03-31 $2.86B $0.92B 32.28%
1998-12-31 $2.72B $0.86B 31.75%
1998-09-30 $2.57B $0.80B 31.28%
1998-06-30 $2.47B $0.67B 27.04%
1998-03-31 $2.43B $0.65B 26.82%
1997-12-31 $2.40B $0.65B 26.85%
1997-09-30 $2.39B $0.64B 26.92%
1997-06-30 $2.36B $0.74B 31.34%
1997-03-31 $2.31B $0.72B 31.07%
1996-12-31 $2.24B $0.68B 30.40%
1996-09-30 $2.16B $0.65B 30.05%
1996-06-30 $2.09B $0.62B 29.48%
1996-03-31 $2.01B $0.57B 28.57%
1995-12-31 $1.94B $0.54B 27.78%
1995-09-30 $1.87B $0.40B 21.29%
1995-06-30 $1.80B $0.37B 20.31%
1995-03-31 $1.72B $0.34B 19.44%
1994-12-31 $1.65B $0.32B 19.36%
1994-09-30 $1.57B $0.41B 25.78%
1994-06-30 $1.50B $0.39B 26.27%
1994-03-31 $1.43B $0.39B 27.10%
1993-12-31 $1.37B $0.38B 27.87%
1993-09-30 $1.32B $0.43B 32.37%
1993-06-30 $1.26B $0.41B 32.59%
1993-03-31 $1.18B $0.38B 32.49%
1992-12-31 $1.09B $0.36B 32.78%
1992-09-30 $0.99B $0.28B 28.77%
1992-06-30 $0.86B $0.24B 28.50%
1992-03-31 $0.73B $0.12B 16.96%
1991-12-31 $0.65B $0.10B 15.19%
1991-09-30 $0.43B $0.00B -0.70%
1991-06-30 $0.33B $-0.04B -11.45%
1991-03-31 $0.26B $0.02B 7.98%
1990-12-31 $0.13B $-0.01B -3.76%
1990-09-30 $0.13B $0.04B 34.40%
1990-06-30 $0.08B $0.03B 39.76%
1990-03-31 $0.03B $0.02B 69.70%
1989-12-31 $0.00B $0.01B -366.67%
1989-09-30 $0.01B $-0.01B -63.64%
1989-06-30 $-0.01B $-0.01B 157.14%
1989-03-31 $-0.01B $-0.01B 171.43%
1988-12-31 $0.04B $-0.01B -29.73%
1988-09-30 $0.05B 0 0.00%
1988-06-30 $0.05B 0 0.00%
1988-03-31 $0.04B 0 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $180.930B $33.424B
Amgen Inc. is the leading biotech companies world wide, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation, bone health & nephrology and neuroscience markets. It developed two most successful drugs, Epogen & Neupogen. Amgen successfully launched two next-generation products, Aranesp & Neulasta and also a biosimilar drug, Prolia/Xgeva. The acquisition of Immunex Corp gave Amgen access to the multi-blockbuster drug, Enbrel. Other products are Repatha, Blincyto, Parsabiv, Evenity, Aimovig, Lumakras/Lumykras, Kanjinti, Mvasi & Amgevita biosimilars. Amgen also has a promising pipeline of cancer drugs. It has one of the strongest cash positions in the biotech sector, which could be used to acquire more pipeline assets that could fuel long-term growth. The erythropoiesis-stimulating agents and granulocyte colony-stimulating factor franchise comprise Epogen/Aranesp and Neupogen/Neulasta respectively. Biosimilar drugs are also a key part of Amgen's growth strategy.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $274.815B 19.39
Gilead Sciences (GILD) United States $155.333B 15.29
Vertex Pharmaceuticals (VRTX) United States $110.246B 28.38
Bristol Myers Squibb (BMY) United States $98.999B 7.41
GSK (GSK) United Kingdom $97.744B 10.87
Regeneron Pharmaceuticals (REGN) United States $73.043B 18.95
Alnylam Pharmaceuticals (ALNY) United States $59.976B 1973.78
CSL (CSLLY) Australia $56.743B 0.00
Argenex SE (ARGX) Netherlands $54.903B 68.18
Insmed (INSM) United States $40.727B 0.00
Novozymes (NVZMY) Denmark $30.566B 0.00
BioNTech SE (BNTX) Germany $24.979B 0.00
Biogen (BIIB) United States $24.166B 9.84
Royalty Pharma (RPRX) United States $22.934B 8.79
Incyte (INCY) United States $20.694B 19.81
Genmab (GNMSF) Denmark $20.087B 14.74
Genmab (GMAB) Denmark $19.416B 14.61
Illumina (ILMN) United States $18.325B 27.51
Roivant Sciences (ROIV) United Kingdom $14.040B 0.00
Exact Sciences (EXAS) United States $12.837B 356.58
Ascendis Pharma (ASND) Denmark $12.737B 0.00
Revolution Medicines (RVMD) United States $12.446B 0.00
Swedish Orphan Biovitrum (BIOVF) Sweden $12.417B 23.10
Guardant Health (GH) United States $11.864B 0.00
Exelixis (EXEL) United States $11.355B 18.18
Avidity Biosciences (RNA) United States $10.674B 0.00
BioMarin Pharmaceutical (BMRN) United States $10.416B 18.89
QIAGEN (QGEN) Netherlands $9.925B 18.84
Moderna (MRNA) United States $9.751B 0.00
Bio-Techne Corp (TECH) United States $9.466B 35.32
Jazz Pharmaceuticals (JAZZ) Ireland $8.611B 33.58
Repligen (RGEN) United States $8.475B 90.70
Halozyme Therapeutics (HALO) United States $8.372B 13.38
Bio-Rad Laboratories (BIO.B) United States $8.238B 29.62
Cytokinetics (CYTK) United States $8.011B 0.00
Abivax SA (ABVX) France $7.853B 0.00
Metsera (MTSR) United States $7.429B 0.00
Merus (MRUS) Netherlands $7.287B 0.00
Axsome Therapeutics (AXSM) United States $6.927B 0.00
Nuvalent (NUVL) United States $6.884B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $6.428B 0.00
Rhythm Pharmaceuticals (RYTM) United States $6.399B 0.00
PTC Therapeutics (PTCT) United States $6.018B 8.17
Vaxcyte (PCVX) United States $5.963B 0.00
Krystal Biotech (KRYS) United States $5.835B 30.17
Legend Biotech (LEGN) United States $5.724B 0.00
Zealand Pharma (ZLDPF) Denmark $5.717B 5.79
Arrowhead Pharmaceuticals (ARWR) United States $5.688B 0.00
Protagonist Therapeutics (PTGX) United States $5.204B 134.26
Alkermes (ALKS) Ireland $5.120B 15.05
Arcellx (ACLX) United States $5.055B 0.00
TG Therapeutics (TGTX) United States $4.915B 11.14
CRISPR Therapeutics AG (CRSP) Switzerland $4.871B 0.00
Cogent Biosciences (COGT) United States $4.817B 0.00
Kymera Therapeutics (KYMR) United States $4.578B 0.00
Akero Therapeutics (AKRO) United States $4.462B 0.00
Praxis Precision Medicines (PRAX) United States $4.453B 0.00
Viking Therapeutics (VKTX) United States $4.408B 0.00
Immunovant (IMVT) United States $4.000B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.999B 33.77
Ligand Pharmaceuticals (LGND) United States $3.961B 97.23
ADMA Biologics Inc (ADMA) United States $3.737B 26.61
Celcuity (CELC) United States $3.649B 0.00
Belite Bio (BLTE) United States $3.579B 0.00
Mirum Pharmaceuticals (MIRM) United States $3.559B 0.00
Mineralys Therapeutics (MLYS) United States $3.505B 0.00
Anbio Biotechnology (NNNN) Germany $3.354B 0.00
Cidara Therapeutics (CDTX) United States $3.332B 0.00
Disc Medicine (IRON) United States $3.286B 0.00
Telix Pharmaceuticals (TLX) Australia $3.219B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.174B 0.00
Ascentage Pharma Group - (AAPG) China $3.143B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.094B 0.00
Tarsus Pharmaceuticals (TARS) United States $3.079B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $3.054B 89.53
Travere Therapeutics (TVTX) United States $3.032B 0.00
GRAIL (GRAL) United States $2.999B 0.00
Jyong Biotech (MENS) Taiwan $2.907B 0.00
Apogee Therapeutics (APGE) United States $2.904B 0.00
Amicus Therapeutics (FOLD) United States $2.894B 234.50
Scholar Rock Holding (SRRK) United States $2.891B 0.00
CG Oncology (CGON) United States $2.879B 0.00
Arcutis Biotherapeutics (ARQT) United States $2.800B 0.00
IDEAYA Biosciences (IDYA) United States $2.790B 0.00
Viridian Therapeutics (VRDN) United States $2.719B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.648B 0.00
Denali Therapeutics (DNLI) United States $2.515B 0.00
Apellis Pharmaceuticals (APLS) United States $2.506B 63.90
Agios Pharmaceuticals (AGIO) United States $2.481B 0.00
Zai Lab (ZLAB) China $2.429B 0.00
Liquidia (LQDA) United States $2.344B 0.00
Bavarian Nordic (BVNRY) Denmark $2.296B 11.10
Recursion Pharmaceuticals (RXRX) United States $2.254B 0.00
Beam Therapeutics (BEAM) United States $2.198B 0.00
Edgewise Therapeutics (EWTX) United States $2.162B 0.00
Adaptive Biotechnologies (ADPT) United States $2.159B 0.00
Arcus Biosciences (RCUS) United States $2.137B 0.00
Structure Therapeutics (GPCR) United States $2.016B 0.00
Vericel (VCEL) United States $2.015B 166.00
Harmony Biosciences Holdings (HRMY) United States $1.975B 10.78
ImmunityBio (IBRX) United States $1.970B 0.00
Zenas BioPharma (ZBIO) United States $1.914B 0.00
Mesoblast (MESO) Australia $1.914B 0.00
ANI Pharmaceuticals (ANIP) United States $1.900B 14.73
UniQure (QURE) Netherlands $1.890B 0.00
Terns Pharmaceuticals (TERN) United States $1.867B 0.00
Sarepta Therapeutics (SRPT) United States $1.867B 0.00
Vera Therapeutics (VERA) United States $1.811B 0.00
Twist Bioscience (TWST) United States $1.805B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.782B 0.00
Spyre Therapeutics (SYRE) United States $1.756B 0.00
Alvotech (ALVO) Luxembourg $1.664B 24.00
Janux Therapeutics (JANX) United States $1.652B 0.00
Nuvation Bio (NUVB) United States $1.608B 0.00
Sionna Therapeutics (SION) United States $1.601B 0.00
Celldex Therapeutics (CLDX) United States $1.576B 0.00
MannKind (MNKD) United States $1.557B 50.70
Maze Therapeutics (MAZE) United States $1.532B 0.00
Dianthus Therapeutics (DNTH) United States $1.522B 0.00
Immunome (IMNM) United States $1.514B 0.00
Stoke Therapeutics (STOK) United States $1.489B 38.91
Syndax Pharmaceuticals (SNDX) United States $1.448B 0.00
Trevi Therapeutics (TRVI) United States $1.396B 0.00
Zymeworks (ZYME) United States $1.384B 0.00
Certara (CERT) United States $1.339B 24.74
Dynavax Technologies (DVAX) United States $1.310B 38.48
NeoGenomics (NEO) United States $1.295B 0.00
NovoCure (NVCR) Jersey $1.274B 0.00
Pharvaris (PHVS) Netherlands $1.269B 0.00
Upstream Bio (UPB) United States $1.261B 0.00
Immatics (IMTX) Germany $1.213B 0.00
Pharming Group (PHAR) Netherlands $1.207B 0.00
CureVac (CVAC) Germany $1.189B 5.52
Oric Pharmaceuticals (ORIC) United States $1.184B 0.00
Rapport Therapeutics (RAPP) United States $1.176B 0.00
Precigen (PGEN) United States $1.150B 0.00
Novavax (NVAX) United States $1.147B 2.92
Mind Medicine (MindMed) (MNMD) United States $1.146B 0.00
Urogen Pharma (URGN) United States $1.120B 0.00
WAVE Life Sciences (WVE) Singapore $1.115B 0.00
MiMedx (MDXG) United States $1.106B 19.66
AbCellera Biologics (ABCL) Canada $1.084B 0.00
Inhibrx Biosciences (INBX) United States $1.081B 0.00
MBX Biosciences (MBX) United States $1.081B 0.00
Phathom Pharmaceuticals (PHAT) United States $1.056B 0.00
Tango Therapeutics (TNGX) United States $1.039B 0.00
Pharming Group (PHGUF) Netherlands $1.027B 153.00
Pacira BioSciences (PCRX) United States $1.016B 11.64
Oculis Holding AG (OCS) Switzerland $1.010B 0.00
Intellia Therapeutics (NTLA) United States $1.004B 0.00
Kodiak Sciences (KOD) United States $0.997B 0.00
Castle Biosciences (CSTL) United States $0.996B 136.48
BridgeBio Oncology Therapeutics (BBOT) United States $0.990B 0.00
Sana Biotechnology (SANA) United States $0.975B 0.00
Nanobiotix S.A - (NBTX) France $0.972B 0.00
Iovance Biotherapeutics (IOVA) United States $0.957B 0.00
Nurix Therapeutics (NRIX) United States $0.956B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.953B 0.00
Palvella Therapeutics (PVLA) United States $0.953B 0.00
Fortrea Holdings (FTRE) United States $0.944B 20.04
Monte Rosa Therapeutics (GLUE) United States $0.932B 44.75
Kura Oncology (KURA) United States $0.929B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.922B 0.00
Rezolute (RZLT) United States $0.922B 0.00
AnaptysBio (ANAB) United States $0.921B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.909B 0.00
BGM Group (BGM) China $0.893B 0.00
CorMedix Inc (CRMD) United States $0.883B 8.18
Arbutus Biopharma (ABUS) United States $0.874B 0.00
Septerna (SEPN) United States $0.861B 0.00
Biohaven (BHVN) United States $0.855B 0.00
Compass Therapeutics (CMPX) United States $0.848B 0.00
Tyra Biosciences (TYRA) United States $0.832B 0.00
LENZ Therapeutics (LENZ) United States $0.829B 0.00
ArriVent BioPharma (AVBP) United States $0.812B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $0.807B 0.00
Bicara Therapeutics (BCAX) United States $0.781B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.781B 0.00
Gyre Therapeutics (GYRE) United States $0.778B 101.00
Rapt Therapeutics (RAPT) United States $0.770B 0.00
Vir Biotechnology (VIR) United States $0.761B 0.00
Geron (GERN) United States $0.734B 0.00
Erasca (ERAS) United States $0.721B 0.00
GH Research (GHRS) Ireland $0.714B 0.00
Astria Therapeutics (ATXS) United States $0.710B 0.00
Replimune (REPL) United States $0.704B 0.00
Ventyx Biosciences (VTYX) United States $0.681B 0.00
MeiraGTx Holdings (MGTX) United States $0.665B 0.00
CytomX Therapeutics (CTMX) United States $0.654B 9.65
Arvinas (ARVN) United States $0.650B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Prime Medicine (PRME) United States $0.601B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.597B 0.00
Myriad Genetics (MYGN) United States $0.592B 0.00
MapLight Therapeutics (MPLT) United States $0.592B 0.00
REGENXBIO (RGNX) United States $0.589B 0.00
Cytek Biosciences (CTKB) United States $0.584B 0.00
Opthea (OPT) Australia $0.583B 0.00
Gossamer Bio (GOSS) United States $0.581B 0.00
Niagen Bioscience (NAGE) United States $0.558B 43.69
Alumis (ALMS) United States $0.549B 0.00
Prothena (PRTA) Ireland $0.548B 0.00
Olema Pharmaceuticals (OLMA) United States $0.545B 0.00
Emergent Biosolutions (EBS) United States $0.542B 5.21
Verastem (VSTM) United States $0.542B 0.00
Monopar Therapeutics (MNPR) United States $0.537B 0.00
Inventiva S.A (IVA) France $0.532B 0.00
Keros Therapeutics (KROS) United States $0.527B 11.23
Lexicon Pharmaceuticals (LXRX) United States $0.523B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.502B 0.00
Anavex Life Sciences (AVXL) United States $0.489B 0.00
Cullinan Therapeutics (CGEM) United States $0.489B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.485B 0.00
NovaBridge Biosciences (NBP) United States $0.481B 0.00
Fulcrum Therapeutics (FULC) United States $0.476B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.458B 0.00
Eton Pharmaceuticals (ETON) United States $0.453B 0.00
Neumora Therapeutics (NMRA) United States $0.449B 0.00
DBV Technologies S.A (DBVT) France $0.442B 0.00
EnGene Holdings (ENGN) Canada $0.432B 0.00
Invivyd (IVVD) United States $0.413B 0.00
Bright Minds Biosciences (DRUG) United States $0.411B 0.00
Kamada (KMDA) Israel $0.407B 19.67
Design Therapeutics (DSGN) United States $0.402B 0.00
XOMA Royalty (XOMA) United States $0.399B 0.00
Absci (ABSI) United States $0.397B 0.00
PureTech Health (PRTC) United States $0.395B 0.00
Ocugen (OCGN) United States $0.387B 0.00
Neurogene (NGNE) United States $0.378B 0.00
LB Pharmaceuticals Inc (LBRX) United States $0.377B 0.00
Northwest Biotherapeutics (NWBO) United States $0.374B 0.00
Alto Neuroscience (ANRO) United States $0.353B 0.00
Benitec Biopharma (BNTC) United States $0.345B 0.00
Aura Biosciences (AURA) United States $0.344B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.343B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.341B 0.00
Amarin (AMRN) Ireland $0.338B 0.00
Entrada Therapeutics (TRDA) United States $0.336B 0.00
Solid Biosciences (SLDB) United States $0.335B 0.00
Tectonic Therapeutic (TECX) United States $0.329B 0.00
X4 Pharmaceuticals (XFOR) United States $0.326B 0.00
AC Immune (ACIU) Switzerland $0.324B 0.00
Annexon (ANNX) United States $0.321B 0.00
Contineum Therapeutics (CTNM) United States $0.318B 0.00
Jade Biosciences (JBIO) United States $0.316B 0.00
Lifecore Biomedical (LFCR) United States $0.296B 0.00
Kyverna Therapeutics (KYTX) United States $0.284B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.283B 0.00
DiaMedica Therapeutics (DMAC) United States $0.282B 0.00
Palisade Bio (PALI) United States $0.279B 0.00
BioAge Labs (BIOA) United States $0.277B 0.00
Zura Bio (ZURA) United States $0.272B 0.00
Prima BioMed (IMMP) Australia $0.271B 0.00
Allogene Therapeutics (ALLO) United States $0.270B 0.00
Immuneering (IMRX) United States $0.268B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.256B 0.00
Black Diamond Therapeutics (BDTX) United States $0.256B 12.47
Candel Therapeutics (CADL) United States $0.253B 0.00
Sagimet Biosciences (SGMT) United States $0.252B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.251B 0.00
Puma Biotechnology (PBYI) United States $0.249B 6.69
Editas Medicine (EDIT) United States $0.248B 0.00
Foghorn Therapeutics (FHTX) United States $0.247B 0.00
Abeona Therapeutics (ABEO) United States $0.245B 4.01
Atea Pharmaceuticals (AVIR) United States $0.239B 0.00
Nautilus Biotechnology (NAUT) United States $0.239B 0.00
C4 Therapeutics (CCCC) United States $0.237B 0.00
Alpha Teknova (TKNO) United States $0.237B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.236B 0.00
Aardvark Therapeutics (AARD) United States $0.236B 0.00
Rani Therapeutics Holdings (RANI) United States $0.235B 0.00
Tenaya Therapeutics (TNYA) United States $0.228B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.228B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.227B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.227B 0.00
Cabaletta Bio (CABA) United States $0.225B 0.00
Voyager Therapeutics (VYGR) United States $0.221B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.221B 0.00
Adherex Technologies (FENC) United States $0.216B 0.00
Adocia (ADOCY) France $0.216B 0.00
Genelux (GNLX) United States $0.210B 0.00
GENFIT S.A (GNFT) France $0.208B 0.00
CAMP4 Therapeutics (CAMP) United States $0.200B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.193B 0.00
Humacyte (HUMA) United States $0.188B 0.00
Cartesian Therapeutics (RNAC) United States $0.188B 0.00
Caribou Biosciences (CRBU) United States $0.186B 0.00
SELLAS Life Sciences (SLS) United States $0.183B 0.00
Crescent Biopharma (CBIO) United States $0.180B 0.00
Molecular Partners AG (MOLN) Switzerland $0.173B 0.00
Forte Biosciences (FBRX) United States $0.172B 0.00
Innate Pharma S.A (IPHA) France $0.168B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.162B 0.00
MaxCyte (MXCT) United States $0.161B 0.00
PepGen (PEPG) United States $0.160B 0.00
Coherus Oncology (CHRS) United States $0.152B 0.00
Seres Therapeutics (MCRB) United States $0.152B 0.00
Nuvectis Pharma (NVCT) United States $0.152B 0.00
Sangamo Therapeutics (SGMO) United States $0.151B 0.00
Elicio Therapeutics (ELTX) United States $0.149B 0.00
Agenus (AGEN) United States $0.147B 0.00
Compugen (CGEN) Israel $0.147B 0.00
Codexis (CDXS) United States $0.147B 0.00
Anika Therapeutics (ANIK) United States $0.146B 0.00
Cardiff Oncology (CRDF) United States $0.145B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.145B 0.00
EXoZymes (EXOZ) United States $0.138B 0.00
Spero Therapeutics (SPRO) United States $0.137B 0.00
Mersana Therapeutics (MRSN) United States $0.137B 0.00
Actuate Therapeutics (ACTU) United States $0.137B 0.00
Cognition Therapeutics (CGTX) United States $0.136B 0.00
Scilex Holding (SCLX) United States $0.136B 0.00
Nkarta (NKTX) United States $0.134B 0.00
Alector (ALEC) United States $0.131B 0.00
Inovio Pharmaceuticals (INO) United States $0.130B 0.00
Alpha Cognition (ACOG) Canada $0.128B 0.00
Opus Genetics (IRD) United States $0.128B 0.00
Climb Bio (CLYM) United States $0.128B 0.00
Entera Bio (ENTX) Israel $0.125B 0.00
Coya Therapeutics (COYA) United States $0.125B 0.00
VTv Therapeutics (VTVT) United States $0.123B 0.00
Immix Biopharma (IMMX) United States $0.121B 0.00
BioHarvest Sciences (BHST) Canada $0.120B 0.00
VistaGen Therapeutics (VTGN) United States $0.117B 0.00
Shattuck Labs (STTK) United States $0.116B 0.00
Turn Therapeutics (TTRX) United States $0.115B 0.00
Fate Therapeutics (FATE) United States $0.114B 0.00
Seer (SEER) United States $0.114B 0.00
Greenwich LifeSciences (GLSI) United States $0.114B 0.00
Starpharma Holdings (SPHRY) Australia $0.113B 0.00
Citius Oncology (CTOR) United States $0.111B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.110B 0.00
Oncolytics Biotech (ONCY) Canada $0.108B 0.00
Pliant Therapeutics (PLRX) United States $0.106B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.105B 0.00
TuHURA Biosciences (HURA) United States $0.105B 0.00
Adicet Bio (ACET) United States $0.102B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.101B 0.00
Kalaris Therapeutics (KLRS) United States $0.100B 0.00
Whitehawk Therapeutics (WHWK) United States $0.099B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.097B 0.00
Atara Biotherapeutics (ATRA) United States $0.097B 6.14
Zentalis Pharmaceuticals (ZNTL) United States $0.095B 0.00
Adverum Biotechnologies (ADVM) United States $0.094B 0.00
Connect Biopharma Holdings (CNTB) United States $0.094B 0.00
Instil Bio (TIL) United States $0.094B 0.00
Quince Therapeutics (QNCX) United States $0.094B 0.00
Biomea Fusion (BMEA) United States $0.091B 0.00
OKYO Pharma (OKYO) $0.090B 0.00
Tevogen Bio Holdings (TVGN) United States $0.087B 0.00
Chrome Holding (MEHCQ) United States $0.087B 0.00
Ovid Therapeutics (OVID) United States $0.085B 0.00
InflaRx (IFRX) Germany $0.085B 0.00
Adagene (ADAG) China $0.085B 0.00
Artiva Biotherapeutics (ARTV) United States $0.083B 0.00
BeyondSpring (BYSI) United States $0.083B 0.00
Estrella Immunopharma (ESLA) United States $0.083B 0.00
XBiotech (XBIT) United States $0.081B 0.00
Sutro Biopharma (STRO) United States $0.079B 0.00
Precision BioSciences (DTIL) United States $0.078B 0.00
Fortress Biotech (FBIO) United States $0.074B 0.00
Clene (CLNN) United States $0.074B 0.00
Repare Therapeutics (RPTX) Canada $0.073B 0.00
Immunic (IMUX) United States $0.070B 0.00
ATyr Pharma (ATYR) United States $0.070B 0.00
BioStem Technologies (BSEM) $0.069B 4.87
Coeptis Therapeutics Holdings (COEP) United States $0.068B 0.00
ABVC BioPharma (ABVC) United States $0.068B 0.00
CervoMed (CRVO) United States $0.067B 0.00
Vor Biopharma (VOR) $0.067B 0.00
ALX Oncology Holdings (ALXO) United States $0.066B 0.00
Oncobiologics (OTLK) United States $0.065B 0.00
TScan Therapeutics (TCRX) United States $0.064B 0.00
MiNK Therapeutics (INKT) United States $0.061B 0.00
Annovis Bio (ANVS) United States $0.061B 0.00
Spruce Biosciences (SPRB) United States $0.057B 0.00
Adlai Nortye (ANL) Cayman Islands $0.056B 0.00
Equillium (EQ) United States $0.050B 0.00
Cue Biopharma (CUE) United States $0.048B 0.00
Senti Biosciences (SNTI) United States $0.047B 0.00
CalciMedica (CALC) United States $0.047B 0.00
Kezar Life Sciences (KZR) United States $0.045B 0.00
Werewolf Therapeutics (HOWL) United States $0.045B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.045B 0.00
TELA Bio (TELA) United States $0.044B 0.00
Skye Bioscience (SKYE) United States $0.044B 0.00
Grace Therapeutics (GRCE) Canada $0.043B 0.00
OnKure Therapeutics (OKUR) United States $0.043B 0.00
Celularity (CELU) United States $0.042B 0.00
Radiopharm Theranostics - (RADX) Australia $0.042B 0.00
Genenta Science S.p.A (GNTA) Italy $0.042B 0.00
Medicus Pharma (MDCX) United States $0.040B 0.00
PDS Biotechnology (PDSB) United States $0.040B 0.00
Applied Therapeutics (APLT) United States $0.039B 0.00
BioAtla (BCAB) United States $0.039B 0.00
Lantern Pharma (LTRN) United States $0.039B 0.00
Tvardi Therapeutics (TVRD) United States $0.039B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.038B 0.00
INmune Bio (INMB) United States $0.038B 0.00
Generation Bio (GBIO) United States $0.038B 0.00
Aligos Therapeutics (ALGS) United States $0.037B 0.00
Galecto (GLTO) Denmark $0.037B 0.00
Xilio Therapeutics (XLO) United States $0.036B 0.00
RenovoRx (RNXT) United States $0.036B 0.00
Hyperion DeFi (HYPD) United States $0.035B 0.00
Pluri (PLUR) Israel $0.034B 0.00
ImageneBio (IMA) United States $0.033B 0.00
Dyadic (DYAI) United States $0.033B 0.00
Alterity Therapeutics - (ATHE) Australia $0.033B 0.00
SAB Biotherapeutics (SABS) United States $0.032B 0.00
Barinthus Biotherapeutics (BRNS) United States $0.032B 0.00
Elutia (ELUT) United States $0.032B 0.00
Rein Therapeutics (RNTX) United States $0.031B 0.00
AN2 Therapeutics (ANTX) United States $0.031B 0.00
Tenax Therapeutics (TENX) United States $0.031B 0.00
Quantum Biopharma (QNTM) Canada $0.029B 0.00
Intensity Therapeutics (INTS) United States $0.029B 0.00
Rallybio (RLYB) United States $0.028B 0.00
Passage Bio (PASG) United States $0.027B 0.00
Q32 Bio (QTTB) United States $0.027B 0.00
Femasys (FEMY) United States $0.027B 0.00
Boundless Bio (BOLD) United States $0.027B 0.00
Jasper Therapeutics (JSPR) United States $0.026B 0.00
NextCure (NXTC) United States $0.026B 0.00
IBio (IBIO) United States $0.026B 0.00
BioXcel Therapeutics (BTAI) United States $0.026B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.026B 0.00
Dare Bioscience (DARE) United States $0.025B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.025B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.025B 0.00
Lexaria Bioscience (LEXX) Canada $0.024B 0.00
Aptevo Therapeutics (APVO) United States $0.024B 0.00
Cadrenal Therapeutics (CVKD) United States $0.024B 0.00
Exicure (XCUR) United States $0.023B 0.00
Apollomics (APLM) United States $0.023B 0.00
Tharimmune (THAR) United States $0.023B 0.00
Synaptogenix (TAOX) United States $0.023B 0.00
Moleculin Biotech (MBRX) United States $0.022B 0.00
Promis Neurosciences (PMN) Canada $0.021B 0.00
Aytu BioPharma (AYTU) United States $0.021B 0.00
Synlogic (SYBX) United States $0.020B 0.00
Clearside Biomedical (CLSD) United States $0.019B 0.00
Athira Pharma (ATHA) United States $0.019B 0.00
Hoth Therapeutics (HOTH) United States $0.018B 0.00
Lisata Therapeutics (LSTA) United States $0.018B 0.00
Cingulate (CING) United States $0.018B 0.00
Allarity Therapeutics (ALLR) United States $0.017B 0.00
FibroBiologics (FBLG) United States $0.017B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.017B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.016B 0.00
MetaVia (MTVA) United States $0.016B 0.00
Abpro Holdings (ABP) United States $0.016B 0.00
NewcelX (NCEL) Switzerland $0.016B 0.00
Longeveron (LGVN) United States $0.015B 0.00
Curis (CRIS) United States $0.015B 0.00
Revelation Biosciences (REVB) United States $0.014B 0.00
GeoVax Labs (GOVX) United States $0.014B 0.00
Soligenix (SNGX) United States $0.014B 0.00
BioCardia (BCDA) United States $0.013B 0.00
Chemomab Therapeutics (CMMB) Israel $0.013B 0.00
Dogwood Therapeutics (DWTX) United States $0.013B 0.00
Edesa Biotech (EDSA) Canada $0.012B 0.00
Novogen (KZIA) Australia $0.012B 0.00
Beyond Air (XAIR) United States $0.011B 0.00
Sensei Biotherapeutics (SNSE) United States $0.011B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.011B 0.00
Biorestorative Therapies (BRTX) United States $0.011B 0.00
Cocrystal Pharma (COCP) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Biofrontera (BFRI) United States $0.010B 0.00
Imunon (IMNN) United States $0.010B 0.00
Propanc Biopharma Inc (PPCB) Australia $0.010B 0.00
Acurx Pharmaceuticals (ACXP) $0.010B 0.00
Advanced Biomed (ADVB) United States $0.010B 0.00
Gelteq (GELS) Australia $0.010B 0.00
Purple Biotech (PPBT) Israel $0.010B 0.00
Bolt Biotherapeutics (BOLT) United States $0.009B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.009B 0.00
Mustang Bio (MBIO) United States $0.009B 0.00
Sunshine Biopharma (SBFM) United States $0.008B 0.00
Mainz Biomed (MYNZ) Germany $0.008B 0.00
Aprea Therapeutics (APRE) United States $0.008B 0.00
Alzamend Neuro (ALZN) United States $0.007B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.007B 0.00
Avalon GloboCare (ALBT) United States $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.007B 0.00
IN8bio (INAB) United States $0.007B 0.00
BioAffinity Technologies (BIAF) United States $0.007B 0.00
BRIACELL THERAP (BCTX) Canada $0.007B 0.00
Evogene (EVGN) Israel $0.006B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.006B 0.00
Ensysce Biosciences (ENSC) United States $0.006B 0.00
Bionano Genomics (BNGO) United States $0.006B 0.00
Entero Therapeutics (ENTO) United States $0.006B 0.00
Silo Pharma (SILO) United States $0.006B 0.00
Cyclerion Therapeutics (CYCN) United States $0.006B 0.00
VivoSim Labs (VIVS) United States $0.006B 0.00
HCW Biologics (HCWB) United States $0.005B 0.00
Arcadia Biosciences (RKDA) United States $0.005B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.005B 0.00
Psyence Biomedical (PBM) Canada $0.005B 0.00
GENPREX (GNPX) United States $0.005B 0.00
KALA BIO (KALA) United States $0.005B 0.00
Polyrizon (PLRZ) Israel $0.005B 0.00
Black Titan (BTTC) United States $0.004B 0.00
GRI Bio (GRI) United States $0.004B 0.00
Atrinsic (PTIX) United States $0.004B 0.00
AquaBounty Technologies (AQB) United States $0.004B 0.00
Onconetix (ONCO) United States $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.003B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
GT Biopharma (GTBP) United States $0.003B 0.00
Alps Group (ALPS) United States $0.003B 2.16
Dermata Therapeutics (DRMA) United States $0.002B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.002B 0.00
Artelo Biosciences (ARTL) United States $0.001B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Cellectis S.A (CLLS) France $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
IO Biotech (IOBT) Denmark $0.000B 0.00
MediciNova (MNOV) United States $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
YD Bio (YDES) $0.000B 0.00